KRYS
Price:
$348.06
Market Cap:
$10.26B
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising programs: KB105 is in Phase I/II clinical trials for patients suffering from deficient autosomal recessive congenital ichthyosis; KB301 is also in Phase I/II development, aiming to ameliorate wrinkles and other signs of aging or damaged skin. Additionally, Krystal Biotech is conducting ...[Read more]
Industry
Biotechnology
IPO Date
2017-09-20
Stock Exchange
NASDAQ
Ticker
KRYS
According to Krystal Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.77B. This represents a change of 76.96% compared to the average of 5.52B of the last 4 quarters.
The mean historical Enterprise Value of Krystal Biotech, Inc. over the last ten years is 1.86B. The current 9.77B Enterprise Value has changed 52.30% with respect to the historical average. Over the past ten years (40 quarters), KRYS's Enterprise Value was at its highest in in the March 2026 quarter at 7.07B. The Enterprise Value was at its lowest in in the September 2017 quarter at -10864742.25.
Average
1.86B
Median
1.04B
Minimum
6.80M
Maximum
6.65B
Discovering the peaks and valleys of Krystal Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.80%
Maximum Annual Enterprise Value = 6.65B
Minimum Annual Increase = -85.02%
Minimum Annual Enterprise Value = 6.80M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 6.65B | 60.54% |
| 2024 | 4.14B | 37.21% |
| 2023 | 3.02B | 61.72% |
| 2022 | 1.87B | 53.06% |
| 2021 | 1.22B | 40.08% |
| 2020 | 870.51M | 25.01% |
| 2019 | 696.35M | 439.26% |
| 2018 | 129.13M | 1.80% |
| 2017 | 6.80M | -85.02% |
The current Enterprise Value of Krystal Biotech, Inc. (KRYS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.60B
5-year avg
3.38B
10-year avg
1.86B
Krystal Biotech, Inc.’s Enterprise Value is greater than CRISPR Therapeutics AG (5.58B), greater than Vaxcyte, Inc. (7.28B), greater than PTC Therapeutics, Inc. (6.11B), less than Arrowhead Pharmaceuticals, Inc. (12.71B), greater than TG Therapeutics, Inc. (8.46B), greater than Alkermes plc (8.73B), greater than Metsera, Inc. (6.98B), greater than Arcellx, Inc. (6.75B), greater than Protagonist Therapeutics, Inc. (7.07B), greater than Teleflex Incorporated (8.00B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.58B | $5.22B | |
| 7.28B | $7.43B | |
| 6.11B | $6.55B | |
| 12.71B | $11.52B | |
| 8.46B | $8.15B | |
| 8.73B | $7.50B | |
| 6.98B | $7.43B | |
| 6.75B | $6.73B | |
| 7.07B | $7.26B | |
| 8.00B | $5.62B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Krystal Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Krystal Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Krystal Biotech, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Krystal Biotech, Inc. (KRYS)?
What is the 3-year average Enterprise Value for Krystal Biotech, Inc. (KRYS)?
What is the 5-year average Enterprise Value for Krystal Biotech, Inc. (KRYS)?
How does the current Enterprise Value for Krystal Biotech, Inc. (KRYS) compare to its historical average?